Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7324
    +0.0001 (+0.01%)
     

  • CRUDE OIL

    83.80
    +0.23 (+0.28%)
     

  • Bitcoin CAD

    87,951.23
    +101.46 (+0.12%)
     

  • CMC Crypto 200

    1,391.93
    +9.36 (+0.68%)
     

  • GOLD FUTURES

    2,346.20
    +3.70 (+0.16%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,763.00
    +195.50 (+1.11%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Midday movers: Activision Blizzard, Oneok, Newmont and more

Investing.com
·1 min read

Investing.com -- Stocks were headed higher as investors await clarity on the outcome of debt ceiling negotiations in Washington. Here are the market movers for May 15.

Activision Blizzard Inc (NASDAQ:ATVI) stock rose 1% after European Union regulators approved Microsoft's $69 billion acquisition of the video game maker. Microsoft Corporation (NASDAQ:MSFT)shares were flat. ONEOK Inc (NYSE:OKE) shares fell 8.5% after it announced a deal for Magellan Midstream Partners LP (NYSE:MMP) for $18.8B. Magellan shares rose 13%. The deal will create one of the largest companies engaged in the transfer of oil and gas. Newmont Goldcorp Corp (NYSE:NEM) shares rose 1.8% after the mining giant struck a $17.5B deal for Australia's Newcrest Mining (OTC:NCMGF) (ASX:NCM) to great the world's biggest gold mining company. Newcrest shares rose 2%. H&R Block Inc (NYSE:HRB) shares fell 3.7% and shares of Intuit Inc (NASDAQ:INTU) fell 1.3% after reports the federal government is looking at offering a free electronic filing platform for taxpayers directly to the Internal Revenue Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares jumped 28% after expert outside advisors to the Food and Drug Administration recommended approval for its muscular dystrophy gene therapy.

Related Articles

Midday movers: Activision Blizzard, Oneok, Newmont and more

ONEOK shares drop on concerns over Magellan pipeline deal

Musk tells Tesla staff he must approve all hiring - the Information